C

China Shineway Pharmaceutical Group Ltd
HKEX:2877

Watchlist Manager
China Shineway Pharmaceutical Group Ltd
HKEX:2877
Watchlist
Price: 8.25 HKD 0.24% Market Closed
Market Cap: 6.8B HKD

EV/EBITDA
Enterprise Value to EBITDA

-0.6
Current
0.3
Median
13
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-0.6
=
Enterprise Value
-499.6m HKD
/
EBITDA
814.7m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-0.5
2-Years Forward
EV/EBITDA
-0.5
3-Years Forward
EV/EBITDA
-0.4